Guidance for Management of Major Depressive Disorder (MDD)

Current Question 1
Guidance for Management of Major Depressive Disorder (MDD)
Question 2
Complete

Which of the following is false?

a. American Psychiatric Association (APA) guidelines for the treatment of depression are frequently updated based on the most recent research.

b. There has been increasing interest in recent years in agents such as glutamate and GABA modulators that act rapidly and can be administered for a relatively short period of time.

c. Cost is a frequent barrier to patients with depression receiving transcranial magnetic stimulation and ketamine infusions.

d. Monoamine-based pharmacotherapies can take 4-6 weeks to take therapeutic effect.

Welcome to Clinical Topics in Depression

Guidance for Management of Major Depressive Disorder (MDD)

Guidance for Management of Major Depressive Disorder (MDD)